https://www.thebodypro.com/author/canadian-aids-treatment-information-exchange
Canadian AIDS Treatment Information Exchange Img

Canadian AIDS Treatment Information Exchange

About CATIE

CATIE's Vision
CATIE envisions a future free of HIV and hepatitis C.

CATIE's Mission
CATIE is Canada's source for accessible, evidence-based information about HIV and hepatitis C prevention, testing, care, treatment and support. CATIE strengthens the national response to HIV and hepatitis C by fostering collaboration and capacity among people living with HIV and/or hepatitis C and other affected populations, frontline service providers and researchers to reduce transmission and improve health and well-being.

Our Services
CATIE is Canada's source for up-to-date, unbiased information about HIV and hepatitis C. We connect people living with HIV or hepatitis C, at-risk communities, healthcare providers and community organizations with the knowledge, resources and expertise to reduce transmission and improve quality of life.

Connect With the Tools You Need
The latest news about HIV and hepatitis C treatment and prevention in clear language

  • Accurate online information
  • Research updates
  • Confidential inquiry line

Resources developed in partnership with organizations across Canada

  • Free publications
  • Program tools
  • Case studies

Events for service providers to share approaches and lessons learned

  • CATIE Forum
  • Regional conferences
  • Learning Institutes

Educational opportunities in person and online

  • Webinars
  • Workshops
  • Training courses

Order a CATIE Brochure
This bilingual brochure provides a brief overview of CATIE's programs and services. Order a copy from the CATIE Ordering Centre.

CATIE's History

Read more about CATIE's history and milestones.

How to Reach CATIE

CATIE (Canadian AIDS Treatment Information Exchange)
555 Richmond Street West, Suite 505
Box 1104
Toronto, Ontario M5V 3B1 Canada

Phone: 416.203.7122 or 1.800.263.1638
Fax: 416.203.8284
E-mail: info@catie.ca
Web: www.catie.ca
Facebook: www.facebook.com/CATIEInfo/
Twitter: https://twitter.com/CATIEinfo

Latest by Canadian AIDS Treatment Information Exchange

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C Img
Hepatitis C

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors Img
Neurocognitive

Large French Study Examines Neuropsychiatric Side Effects With Integrase Inhibitors

This will likely become the landmark study about the overall rate of neuropsychiatric side effects with this class of medicines over the next several years.

Gay Men, Substance Use, and Harm Reduction: It's Time to Act Img
Men Who Have Sex With Men

Gay Men, Substance Use, and Harm Reduction: It's Time to Act

"Placing more attention on meeting the sexual health and holistic wellness needs of gay men affected by sexualized substance use is critical," writes the associate director of Ontario's Gay Men's Sexual Health Alliance.

De-Simplifying Single-Tablet Regimens for HIV Treatment Img

De-Simplifying Single-Tablet Regimens for HIV Treatment

A Canadian study of this cost-saving approach found high acceptance of de-simplification among people already on a single-tablet regimen, and even higher rates among people who were just initiating single-tablet treatment.

Dual Maintenance Therapy With Dolutegravir + Rilpivirine Img
News Analysis

Dual Maintenance Therapy With Dolutegravir + Rilpivirine

In clinical trials called Sword 1 and Sword 2, researchers testing a combination of dolutegravir/rilpivirine (Juluca) found it to be effective and tolerable.

Monkey Study Uncovers the Potential for Vesatolimod and Antibodies in HIV Cure Research Img

Monkey Study Uncovers the Potential for Vesatolimod and Antibodies in HIV Cure Research

Researchers hope that by interacting with the toll-like receptor protein TLR-7 an experimental drug can help increase the immune system's ability to sense and attack HIV and HIV-infected cells.

Italian Study Explores Dual Drug Regimens as Maintenance Treatment Img

Italian Study Explores Dual Drug Regimens as Maintenance Treatment

Researchers found that around 90% of participants who were switched to a dual drug regimen maintained a suppressed viral load over the course of the study.

Combinations of Super Antibodies May Keep HIV at Bay Img

Combinations of Super Antibodies May Keep HIV at Bay

The results from this pilot study are exciting and raise many issues that need to be taken into account for future studies of broadly neutralizing antibodies.

Smartphone Intervention Found Helpful for Young Men Taking PrEP Img

Smartphone Intervention Found Helpful for Young Men Taking PrEP

U.S. researchers have developed PrEPmate, a text messaging service to increase PrEP adherence.

PositiveLinks: Mobile Intervention for People With HIV Img

PositiveLinks: Mobile Intervention for People With HIV

Study results of an intervention that includes a custom smartphone app tailored to the needs and preferences of a rural population of people with HIV living in the southern U.S.